Back to MW MARSHALL WACE, LLP

ORMPORMP
16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ORAMED PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 259,611 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $882,677 as of 2026-Q1. The position was increased (+0.2% shares). ORMP represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$882,677

Current Shares

259,611

Total Value Change

+$296,677

Total Shares Change

+145,905

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
259,611
+0.2%
$882,6770.0%$3.38
25
2025-Q4
New
259,055
-
$738,3080.0%$2.62
34
2024-Q4
Exited
0
-100.0%
$00.0%$2.17
0
2024-Q3
New
22,527
-
$54,9660.0%$2.31
29
2023-Q2
Exited
0
-100.0%
$00.0%$3.33
0
2023-Q1
Decreased
10,553
-71.8%
$23,0060.0%$2.01
0
2022-Q4
Increased
37,399
+31.6%
$449,9090.0%$11.21
31
2022-Q3
Increased
28,409
+45.6%
$185,0000.0%$6.05
31
2022-Q2
New
19,509
-
$90,0000.0%$4.20
30
2021-Q2
Exited
0
-100.0%
$00.0%$12.47
0
2021-Q1
Decreased
11,563
-68.4%
$117,0000.0%$9.43
0
2020-Q4
Decreased
36,632
-37.5%
$155,0000.0%$4.07
0
2020-Q3
Increased
58,648
+21.5%
$153,0000.0%$2.41
27
2020-Q2
Decreased
48,260
-37.6%
$170,0000.0%$3.25
0
2020-Q1
Decreased
77,361
-32.0%
$235,0000.0%$2.78
0
2019-Q4
New
113,706
-
$586,0000.0%$4.62
34

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used